D898_E901 <i>RET</i> Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent Mechanisms
Tommaso Porcelli(University of Naples Federico II), Domenico Salvatore(Federico II University Hospital)
Cited by 5
Related Papers
DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients
|The Journal of Clinical Endocrinology & Metabolism|2017|155